Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients
| Author | : | |
| Rating | : | 4.60 (658 Votes) |
| Asin | : | 0865478007 |
| Format Type | : | paperback |
| Number of Pages | : | 448 Pages |
| Publish Date | : | 2014-12-25 |
| Language | : | English |
DESCRIPTION:
A tough reality check on drug companies and legislation Bad Pharma highlights serious issues with the way the pharmaceutical industry works today. In the book Ben highlights the problems with the industry from several angles, how the tests can be tweaked, how negative tests are not published, how you can make a neutral test appear positive by sub-dividing the goals and then emphasize the fluke positive one. He also shows how the medical journals are part of the problem and the issue with ghost written articles. He shows the problem. Allow me to explain a short quote regarding Big Pharm using pop stars Beyonce, Taylor Swift, and Kanye as the analogy: Explaining Big Pharm Problems Using Pop Stars“…the bar is very low: that drugs must only prove that they are better than nothing, even when there are highly effective treatments on the market already.“ — Goldacre, Ben "Bad Pharma: …”Let me explain the above:Say there’s a drug for ‘XYZ Disease’ on the market named “ ‘Yonce ” that is 80 - 85% effective in stopping growth right in its tracks. Most people us. Eye-Opening Expose of Pharma Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients by Ben Goldacre"Bad Pharma" is the eye-opening expose of the pharmaceutical industry. British physician, academic and science writer, Ben Goldacre follows up his international bestselling book "Bad Science" with yet another enraging investigative book of medical journalism. This insightful book takes you inside a secretive industry that relies on problematic practices for financial gain.This blood raising Eye-Opening Expose of Pharma Book Shark Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients by Ben Goldacre"Bad Pharma" is the eye-opening expose of the pharmaceutical industry. British physician, academic and science writer, Ben Goldacre follows up his international bestselling book "Bad Science" with yet another enraging investigative book of medical journalism. This insightful book takes you inside a secretive industry that relies on problematic practices for financial gain.This blood raising 448-pag. Eye-Opening Expose of Pharma Book Shark Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients by Ben Goldacre"Bad Pharma" is the eye-opening expose of the pharmaceutical industry. British physician, academic and science writer, Ben Goldacre follows up his international bestselling book "Bad Science" with yet another enraging investigative book of medical journalism. This insightful book takes you inside a secretive industry that relies on problematic practices for financial gain.This blood raising 448-pag. 8-pag
With Goldacre's characteristic flair and a forensic attention to detail, Bad Pharma reveals a shockingly broken system and calls for regulation. But Ben Goldacre shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. All these problems have been shielded from public scrutiny because they're too complex to capture in a sound bite. In reality, those tests and trials are often profoundly flawed. He believes we should all be able to understand precisely how data manipulation wor
--Karen Springen . Unfortunately for U.S. Goldacre’s essential exposé will prompt readers to ask more questions before automatically popping a doctor-prescribed pill. Food and Drug Administration on multiple occasions. They “sponsor” trials, which tend to yield favorable results, while negative results often remain unreported. From Booklist In the follow-up to his popular Bad Science (2010), British medical doctor Goldacre reveals how pharmaceutical companies mislead doctors and hurt patients. Not surprisingly, he notes, studies funded by the pharmaceutical industry are that much more likely to get published in these influential journals. And everyone, everywhere should feel unsettled by his discovery that pharmaceutical companies funnel $10 million to $20 million a year to such major medical journals as the New England Journal of Medicine and the Journal of the American Medical Association. readers, h